Eugene Lin, MD, MS, FASN

Associate Professor of Medicine and Health Policy and Management

Image of Eugene Lin, MD, MS, FASN
Is this your profile? Click to edit

Overview

Eugene Lin, MD, MS, is a nephrologist and health services researcher with a focus on economic policies pertaining to kidney disease. He is a nationally recognized expert on the impact of public policy and federal regulation on kidney care, the provision of dialysis in public and private insurance markets, and transitions of care for patients with kidney disease. He is an NIH funded investigator, and his work has been published in leading health policy and medical journals, including JAMA, Health Affairs, and JAMA Internal Medicine.

In addition to his academic roles at USC, he currently serves on the National Kidney Foundation’s Scientific Advisory Board and the American Society of Nephrology’s Transplant Policy Committee. He has also participated as a key stakeholder in multiple Technical Expert Panels for the Centers for Medicare and Medicaid Services.

Dr. Lin completed a postdoctoral fellowship in nephrology at the Stanford School of Medicine and completed his Internal Medicine residency at the Hospital of the University of Pennsylvania.

Education and Training

  • USC, Los Angeles, CA — Visiting Scholar — 2018
  • Stanford University School of Medicine, Palo Alto, CA — Fellow — 2018 — Nephrology
  • Stanford University, Stanford, CA — M.S. — 2017 — Health Services Research
  • Hospital of the University of Pennsylvania, Philadelphia, CA — Resident — 2014 — Internal Medicine
  • Hospital of the University of Pennsylvania, Philadelphia, CA — Intern — 2012
  • Baylor College of Medicine, Houston, TX — M.D. — 2011 — Medicine
  • Stanford University, Stanford, CA — B.S. — 2006 — Biology, minor in Mathematics

Research Funding

  • Elucidating the Mechanisms of Racial and Ethnic Disparities in Dialysis Quality
    NIH · R01DK137223 · Sep 1, 2023 – Jun 30, 2028 · Role: Principal Investigator
  • Comparing Dialysis Provision and Outcomes Between Medicare Advantage and Fee-for-Service Medicare
    NIH · R03DK131239 · Jul 1, 2022 – Jun 30, 2024 · Role: Principal Investigator
  • The Impact of Medicare Advantage on Patients with End-Stage Kidney Disease
    American Society of Nephrology (KidneyCure) · Jul 1, 2021 – Jun 30, 2023 · Role: Principal Investigator
  • Investigating the Economic and SocialDeterminants of Home Dialysis Drop-Out
    NIH · K08DK118213 · Aug 15, 2018 – May 31, 2024 · Role: Principal Investigator
  • Investigating the Appropriateness of 30-Day Rehospitalizations in Dialysis Patients
    NIH · F32DK107123 · Jul 20, 2015 – Jul 19, 2018 · Role: Principal Investigator

Research Keywords

  • Dialysis Delivery
  • Multidisciplinary Care in Kidney Disease
  • Value-Based Purchasing
  • Medicare Payment Policy
  • Decision Analysis

Publications

  • Health Policy Trends in Kidney Disease. Adv Chronic Kidney Dis. 2022 01; 29(1):3-4.. View in PubMed
  • Patient Frailty and Functional Use of Hemodialysis Vascular Access: A Retrospective Study of the US Renal Data System. Am J Kidney Dis. 2022 07; 80(1):30-45.. View in PubMed
  • Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015. Pigment Cell Melanoma Res. 2021 11; 34(6):1049-1061.. View in PubMed
  • Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis. Value Health. 2021 11; 24(11):1592-1602.. View in PubMed
  • Payment for Dialysis Services in the Individual Market. JAMA Intern Med. 2021 05 01; 181(5):698-699.. View in PubMed
  • Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure. Circ Cardiovasc Qual Outcomes. 2021 03; 14(3):e006461.. View in PubMed
  • The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare. JAMA Netw Open. 2021 03 01; 4(3):e212113.. View in PubMed
  • Hospitalizations among adults with chronic kidney disease in the United States: A cohort study. PLoS Med. 2020 12; 17(12):e1003470.. View in PubMed
  • Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database. Cancer Med. 2021 01; 10(2):575-585.. View in PubMed
  • Competing with a pandemic: Trends in research design in a time of Covid-19. PLoS One. 2020; 15(9):e0238831.. View in PubMed